The effect of febuxostat on diastolic function in hyperuricemic patients with LV diastolic dysfunction
Phase of Trial: Phase IV
Latest Information Update: 03 Sep 2015
Price : $35 *
At a glance
- Drugs Febuxostat (Primary) ; Benzbromarone
- Indications Hyperuricaemia; Left ventricular dysfunction
- Focus Therapeutic Use
- 04 Oct 2014 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 04 Apr 2014 Planned End Date changed from 30 Jun 2014 to 31 Aug 2014 as reported by University Hospital Medical Information Network - Japan.
- 13 Nov 2013 New trial record